Amerigen Pharmaceuticals Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 24
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Amerigen Pharmaceuticals General Information

Description

Developer of generic pharmaceutical products based in United States and China. The company engages in the manufacture and sale of generic pharmaceutical products and provides executive management, product and business development, finance, regulatory affairs and commercial operations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 9 Polito Avenue
  • Suite 900
  • Lyndhurst, NJ 07071
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amerigen Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amerigen Pharmaceuticals‘s full profile, request access.

Request a free trial

Amerigen Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amerigen Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Amerigen Pharmaceuticals‘s full profile, request access.

Request a free trial